Jamal Saeh

3PUBLICATIONS
50CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 21, 2024
A Phase 1 First-in-Human Study of the MCL-1 Inhibitor AZD5991 in Patients with Relapsed/Refractory Hematologic Malignancies.

Pinkal Desai, Sagar Lonial, Amanda Cashen

|Jun 08, 2023
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer.

Kavya Ramkumar, Azusa Tanimoto, Carminia M Della Corte

Pageof 1